“This is a problem with a solution. The solution is awareness of the colorectal cancer problem and getting screened.”
– Dr. Thomas K. Weber, Founder, Colon Cancer Foundation

My late father Dr. Thomas Weber founded the Colon Cancer Foundation (CCF) because he recognized the power of preventing colorectal cancer and diagnosing it early through screenings. The screenings identify precancerous polyps and early stage growths that doctors can remove.

The CCF has now led the mission of raising awareness and increasing screenings for 19 years.

As we enter Colorectal Cancer Awareness Month in March, you can take direct action today to solve the colorectal cancer problem and save lives:

Talk to your doctor about getting a colonoscopy if you are 45 years or older. If you are younger than 45 but have one or more family members that were diagnosed with colorectal cancer, ask your doctor if you should start screening earlier.

Participate and help increase visibility for CCF’s awareness campaigns and fund colorectal cancer screenings.

Donate Now: The funds collected through your fundraising efforts enable us to reach more people with life saving public awareness, prevention, and research programs.

Two Reasons to Show Your Support

Reason #1: Screenings were down due to COVID-19 but are beginning to pick up again. That’s great news, but it is critical that colonoscopy rates grow past pre-pandemic levels to save lives.

Reason #2:  Deaths from colorectal cancer in people ages 0-49 are increasing. Educating our friends and family with high risk factors can help identify and treat the disease in young people.

CCF’s March Awareness events, tools, and resources are designed to maximize the impact of your donations.

Thank you for taking action!

Sincerely,

Nick Weber

P.S. Your support, plus our ongoing work to mobilize the medical community to address colorectal cancer in young people with the Early-Age Onset Colorectal Cancer Summit, will make a difference!

patient consultation

The new year brought news of two success stories in our fight to increase accessibility to colorectal cancer (CRC) screening. The first, is a change in private insurance coverage requirements for colonoscopies. The second is from Kentucky, where a pharmacy protocol was passed to allow at-home fecal tests to be taken care of like a regular prescription. More details below.

Coverage for Screening Colonoscopy Without Cost Sharing

A document jointly released by the Departments of Labor, Health and Human Services, and Treasury on January 10th 2022 categorically states that private insurance plans are required to cover a follow-up colonoscopy after a positive non-invasive stool-based test or a direct visualization screening test, without any cost-sharing with respect to the colonoscopy for the health plan beneficiary. This coverage requirement will go into effect on May 31, 2022, one year after the updated recommendation on CRC screening was issued by the US Preventive Services Task Force

The Affordable Care Act requires health insurers to fully cover preventive screening. However, colonoscopies done after a stool-based test (such as FIT, gFOBT, or MT-sDNA/sDNA-FIT) were considered diagnostic and were not covered in the same way as decennial colonoscopies. This policy change however, is only applicable to private insurance holders; it does not apply to those who are enrolled in traditional Medicaid and Medicare plans.

Kentucky: Easy Access to Stool-Based Testing

On September 28, 2021, a new pharmacy protocol passed in the state of Kentucky will allow fecal immunochemical test (FIT) or stool DNA test (sDNA-FIT) to be taken care of at the pharmacy like a flu shot or regular prescription.

With the screening age for average-risk adults lowered to 45 years, it is important to eliminate the barriers for those who actually want and need screening. As we have seen over the last couple of years though, the COVID-19 pandemic has prevented many from getting the care that they need, including preventive care services. This bill has truly come at the right time. 

“Kentucky is the first state in the nation to have this type of protocol passed, and why not here?” said Dr. Whitney Jones, founder of the Colon Cancer Prevention Project, which is based out of Kentucky. “Colorectal cancer is treatable and preventable when caught early, and this new protocol will allow the general population more avenues to get screened on time.”

 

Gargi Patel is a Colon Cancer Prevention Intern with the Colon Cancer Foundation.

The COVID-19 pandemic has affected nearly every aspect of life from schools to offices and, most importantly, healthcare. While certain things may have gone back to normal, the healthcare space continues to struggle. During a discussion at the National Colorectal Cancer Roundtable (NCCRT) Annual Meeting, panelists shared how their respective organizations  adapted to the pandemic to ensure continued delivery of colorectal cancer (CRC) screening.

Rachel Issaka from the Fred Hutchinson Cancer Research Center kicked off the discussion with the history of the COVID-19 pandemic in the U.S., starting with when the SARS-CoV-2 virus reached the U.S and the government declared a national emergency on March 13th, 2020, due to the rapid spread of the virus. A day later, on March 14th, the office of the U.S. Surgeon General advised hospitals to reschedule all elective procedures. Subsequently, the Gastroenterology Society released a statement that recommended all endoscopies and clinical practices be rescheduled along with other non-urgent procedures and the Centers for Disease Control & Prevention (CDC) recommended that healthcare systems prioritize urgent visits and delay elective care. The American Cancer Society (ACS) advised patients to postpone elective care, including cancer screenings, if they are at average risk for cancer and did not have any signs or symptoms. 

Following these recommendations, many adults delayed or avoided medical care. A study conducted in June 2020 by the CDC found that:

  • 41% of U.S. adults had delayed or avoided treatment
  • 12% had avoided urgent and emergency care 
  • 32% avoided routine care

Another study conducted in April 2020 found that cancer diagnoses decreased by 46% as compared to the year before, and CRC diagnoses dropped by 49%. The primary cause for this drop in diagnoses was delayed screenings for individuals who had symptoms but did not want to use the healthcare system during the pandemic. CRC screenings were down 25% between March of 2020 and March of 2021. It is estimated that these delays in screening and diagnoses will be responsible for an additional 4,500 deaths from CRC by the year 2030. 

Fortunately, organizations such as the Lincoln Community Health System in Newport, Oregon, recognized this growing gap in screening and diagnosis of CRC and came up with solutions. Jaraka Carver, LPN, from Lincoln Community Health Center, who was planning on running a CRC awareness campaign in March 2020, witnessed the project being derailed by the pandemic. Instead, after seeing the growing gap in CRC diagnosis she and her team implemented a bi-annual FIT mailing program to reach out to individuals and remind them that they were overdue for a CRC screening, and then sent them an at-home FIT test. Of the kits that were sent out:

  • 33.5% came back for testing, of which 15 came back as abnormal 
  • 30 individuals were referred for colonoscopies, 20 of whom completed the colonoscopy and 1 was diagnosed with cancer 

Virginia Mason Franciscan Health in the Pacific Northwest was also looking to increase CRC screenings among their constituents. Their divisional vice president, Michael Anderson, had partnered with ACS on a program to increase CRC screenings to 70%. However, once the pandemic hit, they had to change directions. With the goal of scheduling annual wellness visits during the pandemic, they specifically focused on vulnerable populations and clearly communicated Medicare’s new rule that a patient could complete a visit in person, online, or by phone. 

The organization also began reaching out to patients who were overdue for an annual visit and implemented a digital tool that helped prioritize patients by their likelihood of completing a CRC screening test. The program had a 40% success rate: they scheduled 5,300 annual wellness visits, completed 1,325 cancer screenings, and saved nearly 8.16 years of life. On a population level, this program allowed 41 more men and women to spend an extra year of life with their friends and family because they were screened for CRC. 

The panel concluded with a question and answer session where participants were able to ask the presenters questions regarding the effects of SARS-CoV-2 on CRC screenings. This meeting stressed the importance of annual screenings as well as the importance of adapting to different situations and needs, with a focus on ensuring that patients are able to achieve the best health outcome possible. 

 

*Additional Information on the NCCRT annual meeting can be found at 2021 80% in Every Community Conference & NCCRT Annual Meeting – National Colorectal Cancer Roundtable  

Presenters slides can be downloaded using this link https://nccrt.org/download/101349/ 

 

Abigail Parker is a Colon Cancer Prevention Intern with the Colon Cancer Foundation.